PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50124C00051Execution of the clinical METHOD comparison — Lumos Diagnostics, Inc

Lumos Diagnostics, Inc holds $9.2M across 1 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Jun 30, 2027 PoP end — agencies typically plan 12–18 months ahead.

Barda - Aspr / Daappo / Barda Dcma

Awarding office

Lumos Diagnostics, Inc

Recipient

Jun 30, 2027

PoP end

$9.2M

Obligated

$9.2M

Potential

541714

NAICS

AN42

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Lumos Diagnostics, Inc — $90

Contract facts

NONE

Contract number75A50124C00051

AgencyBarda - Aspr / Daappo / Barda Dcma

Awarding officeBarda - Aspr / Daappo / Barda Dcma

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentLumos Diagnostics, Inc

CAGE82T59

UEICRKMAE3F8ZJ1

NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCAN42

Place of performanceCARLSBAD CA

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

Related solicitationBAA-23-100-SOL-00004

PoP startSep 25, 2024

PoP end (current)Jun 30, 2027

Obligated$9.2M

Current value$9.2M

Potential value$9.2M

EXECUTION OF THE CLINICAL METHOD COMPARISON STUDY AND REGULATORY SUBMISSION REQUIRED TO BE GRANTED CLIA-WAIVER FROM THE FDA FOR FEBRIDX RESPONSE TO BAA-23-100-SOL-00004 is a federal NONE award for Barda - Aspr / Daappo / Barda Dcma held by Lumos Diagnostics, Inc. Estimated value $9.2M ($9.2M obligated). Current period of performance ends Jun 30, 2027. Last award drew 1 bidder. Place of performance: CARLSBAD CA. Related solicitation BAA-23-100-SOL-00004.

EXECUTION OF THE CLINICAL METHOD COMPARISON STUDY AND REGULATORY SUBMISSION REQUIRED TO BE GRANTED CLIA-WAIVER FROM THE FDA FOR FEBRIDX RESPONSE TO BAA-23-100-SOL-00004

Recompete timing

Public

● Expiring in 296 days

Current PoP ends Jun 30, 2027 (296 days remaining). Agencies typically plan 12–18 months ahead — at 9.7 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Lumos Diagnostics, Inc — $9.2M obligated across 1 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$9.2M · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75A50124C00051?

75A50124C00051 (Execution of the clinical METHOD comparison) is a Barda - Aspr / Daappo / Barda Dcma award with a potential value of $9.2M, currently held by Lumos Diagnostics, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75A50124C00051?

Barda - Aspr / Daappo / Barda Dcma awarded 75A50124C00051 to Lumos Diagnostics, Inc (potential $9.2M).

Who is the incumbent on 75A50124C00051?

Lumos Diagnostics, Inc is the incumbent with $9.2M across 1 related awards in SCOUT’s public footprint. The current period of performance ends Jun 30, 2027.

When does Lumos Diagnostics, Inc’s 75A50124C00051 come up for recompete?

SCOUT tracks a period-of-performance end of Jun 30, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 75A50124C00051 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action Aug 27, 2025